Metabolites
Displaying compounds 14801 - 14825 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB00729 | Delta(6)-trans,Delta(8)-cis-leukotriene B4 | (5S,6E,8Z,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid | C20H32O4 336.4657 |  |
| YMDB00730 | leukotriene B4 71160-24-2 | (5S,6E,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid | C20H32O4 336.4657 |  |
| YMDB00741 | nicotinic acid D-ribonucleotide | 3-carboxy-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-1lambda5-pyridin-1-ylium | C11H15NO9P 336.2119 |  |
| YMDB00320 | S-Formylglutathione 50409-81-9 | (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-(formylsulfanyl)ethyl]carbamoyl}butanoic acid | C11H17N3O7S 335.334 |  |
| YMDB00668 | 7,8-dihydroneopterin 3'-phosphate | [(2R,3S)-3-(2-amino-4-oxo-1,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropoxy]phosphonic acid | C9H14N5O7P 335.2105 |  |
| YMDB00138 | Nicotinamide ribotide 1094-61-7 | 3-carbamoyl-1-[(2R,3R,4S,5R)-5-[(hydrogen phosphonooxy)methyl]-3,4-dihydroxyoxolan-2-yl]-1lambda5-pyridin-1-ylium | C11H15N2O8P 334.2192 |  |
| YMDB00781 | 1-(sn-glycero-3-phospho)-1D-myo-inositol | [(2S)-2,3-dihydroxypropoxy]({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid | C9H19O11P 334.2143 |  |
| YMDB01733 | Malvidin 643-84-5 | 3,5,7-trihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-1λ⁴-chromen-1-ylium chloride | C17H15O7 331.2968 |  |
| YMDB00451 | dAMP 653-63-4 | {[(2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}phosphonic acid | C10H14N5O6P 331.2218 |  |
| YMDB02313 | 1-monohexadecanoylglycerol | (2R)-2,3-dihydroxypropyl hexadecanoate | C19H38O4 330.5026 |  |
| YMDB13381 | MG(16:0/0:0/0:0) | (2R)-2,3-dihydroxypropyl hexadecanoate | C19H38O4 330.5026 |  |
| YMDB00453 | 3',5'-cyclic IMP 3545-76-4 | (4aR,6R,7R,7aS)-2,7-dihydroxy-6-(6-hydroxy-9H-purin-9-yl)-hexahydro-2λ⁵-furo[3,2-d][1,3,2]dioxaphosphinin-2-one | C10H11N4O7P 330.1907 |  |
| YMDB16188 | Dihydroceramide | N-[(2S,3R)-1,3-dihydroxyoctadecan-2-yl]formamide | C19H39NO3 329.5179 |  |
| YMDB00023 | 3',5'-cyclic AMP 60-92-4 | (4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-2lambda5-furo[3,2-d][1,3,2]dioxaphosphinin-2-one | C10H12N5O6P 329.2059 |  |
| YMDB00565 | 2',3'-cyclic AMP 634-01-5 | (3aR,4R,6R,6aR)-4-(6-amino-9H-purin-9-yl)-2-hydroxy-6-(hydroxymethyl)-tetrahydro-2H-2λ⁵-furo[3,4-d][1,3,2]dioxaphosphol-2-one | C10H12N5O6P 329.2059 |  |
| YMDB13382 | MG(16:1(11Z/0:0)/0:0/0:0) | (2R)-2,3-dihydroxypropyl (11Z)-hexadec-11-enoate | C19H36O4 328.493 |  |
| YMDB13383 | MG(16:1(9Z/0:0)/0:0/0:0) | (2R)-2,3-dihydroxypropyl (9Z)-hexadec-9-enoate | C19H36O4 328.493 |  |
| YMDB16220 | MG(16:1(9Z)/0:0/0:0) | (2S)-2,3-dihydroxypropyl (9Z)-hexadec-9-enoate | C19H36O4 328.4867 |  |
| YMDB02323 | Stearic acid-propyl ester | propyl octadecanoate | C21H42O2 326.557 |  |
| YMDB13271 | LPA(10:0/0:0) | [3-(decanoyloxy)-2-hydroxypropoxy]phosphonic acid | C13H27O7P 326.326 |  |
| YMDB13290 | LPA(0:0/10:0) | [2-(decanoyloxy)-3-hydroxypropoxy]phosphonic acid | C13H27O7P 326.326 |  |
| YMDB00766 | 6,7-Dimethyl-8-(1-D-ribityl)lumazine 5118-16-1 | 6,7-dimethyl-8-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-2,3,4,8-tetrahydropteridine-2,4-dione | C13H18N4O6 326.3052 |  |
| YMDB01693 | Fertaric acid | 2-hydroxy-3-{[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}butanedioic acid | C14H14O9 326.2556 |  |
| YMDB00780 | Pseudouridine 5'-phosphate 1157-60-4 | {[(2R,3S,4R,5S)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid | C9H13N2O9P 324.1813 |  |
| YMDB00049 | Uridine 5'-monophosphate 58-97-9 | {[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid | C9H13N2O9P 324.1813 |  |